Preventing Relapses in Schizophrenia
March 25, 2019 – 
Insight regarding treatment resistance in schizophrenia and recommendations for ensuring optimal use of antipsychotic therapy to reduce the risk of relapse.
Consequences of Relapses in Schizophrenia
March 25, 2019 – 
Clinicians review the consequences of relapses on patients with schizophrenia and provide insight on counseling patients on the proper use of antipsychotic therapy.
Predictors of Relapse in Schizophrenia
March 18, 2019 – 
Experts in the management of patients with schizophrenia highlight typical predictors of relapse and stress the importance of counseling patients on what to monitor for.
Current Challenges in the Treatment of Schizophrenia
March 18, 2019 – 
Challenges surrounding the treatment of patients with schizophrenia and their overall impact on patient care and rates of relapse.
Optimal Treatment of Schizophrenia: Take-Home Messages
January 17, 2019 – 
John M. Kane, MD, provides several take-home messages regarding the optimal management of schizophrenia given his understanding of the current treatment landscape.
Schizophrenia: Switching to a Long-Acting Injectable
January 10, 2019 – 
Given potential resistance in the clinical setting, John M. Kane, MD, explains the logistics of switching a patient with schizophrenia to a long-acting injectable formulation.
Overcoming Obstacles to LAIs in Schizophrenia Management
January 10, 2019 – 
A concise description of how to overcome resistance and barriers to prescribing long-acting injectables for patients with schizophrenia is provided by John M. Kane, MD.
Adherence to Oral Agents in Schizophrenia Management
January 03, 2019 – 
John M. Kane, MD, considers potential approaches in the schizophrenia treatment landscape to mitigate the impact of patient nonadherence to oral agents.
Benefit of Long-Acting Injectables in Schizophrenia
January 02, 2019 – 
John M. Kane, MD, outlines the benefits of long-acting injectables compared with oral agents in the setting of schizophrenia management.
Schizophrenia: Consequences of Multiple Relapses
December 26, 2018 – 
Considering both individual and systemic costs, John M. Kane, MD, emphasizes the consequences of multiple relapses in the treatment landscape of schizophrenia.
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.

Sign In

Not a member? Sign up now!